Use of administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy.
Acromegaly
Administrative health databases
Algorithm
Incidence
Prevalence
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
04
06
2018
accepted:
25
07
2018
pubmed:
3
8
2018
medline:
28
7
2019
entrez:
3
8
2018
Statut:
ppublish
Résumé
Recent studies from national registries have described changing patterns in epidemiology of acromegaly. Our retrospective study used administrative databases to estimate prevalence and incidence of acromegaly in the Piedmont Region, Italy. This study was conducted in Piedmont between 2012 and 2016 on administrative health databases for inpatients and outpatients of any age. Enrollees were included if claims suggestive of acromegaly were identified in at least two of the following databases: Drug Claims Registry, Hospital Information System, Co-payment Exemption Registry and Outpatient Specialist Service Information System. 369 individuals (M = 146, F = 223) met our criteria. Overall incidence was 5.3 per million person years (95% CI 4.2-6.7), and prevalence was 83 cases per million inhabitants (95% CI 75-92). Mean age was 50.9 years. Both incidence and prevalence were slightly higher among women (rate ratio 1.08, prevalence ratio 1.43). Age-specific incidence was similar between sexes up to 39 years and diverged thereafter, with an increasing trend recorded among men. Prevalence was higher in women aged 40-79 years, and increased continuously up to 79 years in both sexes. This is the first population-based study conducted in Italy to estimate incidence and prevalence of acromegaly and results show a higher prevalence than previously reported. Although our algorithm requires proper validation, it constitutes a promising tool to describe the epidemiology of acromegaly.
Identifiants
pubmed: 30069856
doi: 10.1007/s40618-018-0928-7
pii: 10.1007/s40618-018-0928-7
doi:
Types de publication
Journal Article
Langues
eng
Pagination
397-402Références
Eur J Endocrinol. 2004 Oct;151(4):439-46
pubmed: 15476442
J Clin Endocrinol Metab. 2006 Dec;91(12):4769-75
pubmed: 16968795
Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):498-505
pubmed: 17115347
Eur J Endocrinol. 2007 Oct;157(4):399-409
pubmed: 17893253
J Clin Invest. 2009 Nov;119(11):3189-202
pubmed: 19884662
Endocrinol Nutr. 2010 Feb;57(2):39-42
pubmed: 20189894
J Clin Endocrinol Metab. 2010 Sep;95(9):4192-6
pubmed: 20610592
J Clin Endocrinol Metab. 2011 Apr;96(4):894-904
pubmed: 21474686
Endocr Pract. 2011 Jul-Aug;17 Suppl 4:1-44
pubmed: 21846616
Eur J Endocrinol. 2012 Aug;167(2):189-98
pubmed: 22596288
Nat Rev Endocrinol. 2012 Oct;8(10):605-11
pubmed: 22733271
Endocrinol Nutr. 2013 Oct;60(8):470-4
pubmed: 23246411
Ulster Med J. 1990 Apr;59(1):55-62
pubmed: 2349750
J Clin Endocrinol Metab. 2013 Aug;98(8):3190-8
pubmed: 23737543
Nat Rev Endocrinol. 2014 Apr;10(4):243-8
pubmed: 24566817
Eur J Endocrinol. 2014 Oct;171(4):519-26
pubmed: 25084775
Radiology. 2014 Nov;273(2):322-5
pubmed: 25340267
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51
pubmed: 25356808
Pituitary. 2015 Dec;18(6):803-7
pubmed: 25893613
Eur J Endocrinol. 2015 Nov;173(5):655-64
pubmed: 26423473
Pituitary. 2016 Jun;19(3):262-7
pubmed: 26792654
Eur J Endocrinol. 2016 Sep;175(3):181-90
pubmed: 27280374
Endocr Pract. 2016 Nov;22(11):1327-1335
pubmed: 27540880
Pituitary. 2017 Feb;20(1):4-9
pubmed: 27743174
Endocr Pract. 2017 Apr 2;23(4):422-431
pubmed: 28095048
J Endocrinol Invest. 2017 Jun;40(6):577-589
pubmed: 28176221
Acta Med Scand. 1988;223(4):327-35
pubmed: 3369313
Clin Endocrinol (Oxf). 1980 Jan;12(1):71-9
pubmed: 7379316